Skip to main content
Intermediate Technical IVT

TORCH screening

Also written as: TORCH — Toxoplasmosis, Other, Rubella, Cytomegalovirus, Herpes

Laboratory testing for maternal infections that can cause congenital abnormalities: Toxoplasmosis, Other, Rubella, Cytomegalovirus, and Herpes simplex.

Full Definition

TORCH screening refers to a panel of blood tests performed during pregnancy to detect maternal infections that pose risks for vertical transmission and fetal complications. The acronym stands for Toxoplasmosis, Other infections (including syphilis, varicella, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes simplex virus. These pathogens can cross the placenta and cause serious congenital infections, growth restriction, developmental delays, or structural abnormalities. The screening typically involves testing for both IgG and IgM antibodies to determine immune status and identify acute infections requiring intervention.

Usage

Usage note: Always written in all caps as an acronym.

In Context

  • "TORCH screening revealed positive CMV IgM antibodies indicating recent maternal infection." — Laboratory report
  • "The patient's TORCH titers showed immunity to rubella but susceptibility to toxoplasmosis." — Prenatal record

Also known as

TORCH panel congenital infection screen

Don't confuse with

STI screening routine prenatal labs

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON